Monday, August 24, 2026

Celltrion’s Remsima SC: The Leading Autoimmune Drug with 68% Market Share in Europe

Celltrion's treatments for autoimmune diseases and cancer maintain strong market positions in Europe, bolstered by stable prescriptions and new products.

Rheumatoid Arthritis Breakthrough: How Oral Pills Could Replace Injections

Researchers from Catholic University of Korea are developing an oral form of rheumatoid arthritis injections with a U.S. institute.

Chaos on the Field: Euro 2024 Plagued by Safety Issues and Fan Misconduct

The UEFA European Football Championship (Euro) 2024...

Tag: Takeru Satoh

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.